ABSCI CORP Increase (Decrease) in Accounts Receivable
ABSCI CORP (ABSI) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-11
- ABSCI CORP increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $0.00.
- ABSCI CORP increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ABSCI CORP increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.00M.
- ABSCI CORP increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $300.00K, a 78.65% decline year-over-year.
- ABSCI CORP increase (decrease) in accounts receivable for fiscal 2025 was $0.00.
- ABSCI CORP increase (decrease) in accounts receivable for fiscal 2024 was -$2.24M, a 436.19% decline from fiscal 2023.
- ABSCI CORP increase (decrease) in accounts receivable for fiscal 2023 was $666.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | -$1.00M derived: sum of 3 quarters · filed 2026-08-11 | -$700.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | -$1.00M derived: sum of 2 quarters · filed 2026-05-07 | -$700.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.38M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$700.00K derived: sum of 2 quarters · filed 2026-03-24 | -$1.38M derived: sum of 3 quarters · filed 2026-08-11 | $0.00 10-K · filed 2026-03-24 |
| 2025-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$384.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.00M 10-Q · filed 2025-11-12 | -$500.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$684.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $700.00K 10-Q · filed 2026-08-11 | -$800.00K derived: sum of 3 quarters · filed 2026-08-11 | $605.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $1.38M 10-Q · filed 2026-05-07 | -$116.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.29M derived: sum of 3 quarters · filed 2026-05-07 | $1.29M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$95.00K derived: sum of 2 quarters · filed 2026-03-24 | -$92.00K derived: sum of 3 quarters · filed 2026-03-24 | -$2.24M 10-K · filed 2026-03-24 |
| 2024-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.41M derived: sum of 2 quarters · filed 2025-11-12 | -$739.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.14M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$2.15M 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $666.00K 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |